- Home
- ICCC vs SNAL Comparison
ICCC vs SNAL Comparison
Compare ICCC & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- SNAL
- Stock Information
- Founded
- ICCC 1982
- SNAL 2000
- Country
- ICCC United States
- SNAL United States
- Employees
- ICCC N/A
- SNAL N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- SNAL Computer Software: Prepackaged Software
- Sector
- ICCC Health Care
- SNAL Technology
- Exchange
- ICCC Nasdaq
- SNAL Nasdaq
- Market Cap
- ICCC 60.1M
- SNAL 51.0M
- IPO Year
- ICCC 1987
- SNAL 2022
- Fundamental
- Price
- ICCC $5.90
- SNAL $0.99
- Analyst Decision
- ICCC
- SNAL
- Analyst Count
- ICCC 0
- SNAL 0
- Target Price
- ICCC N/A
- SNAL N/A
- AVG Volume (30 Days)
- ICCC 12.6K
- SNAL 196.0K
- Earning Date
- ICCC 08-14-2025
- SNAL 08-19-2025
- Dividend Yield
- ICCC N/A
- SNAL N/A
- EPS Growth
- ICCC N/A
- SNAL N/A
- EPS
- ICCC 0.20
- SNAL 0.04
- Revenue
- ICCC $28,274,756.00
- SNAL $90,462,190.00
- Revenue This Year
- ICCC N/A
- SNAL $24.50
- Revenue Next Year
- ICCC N/A
- SNAL $20.27
- P/E Ratio
- ICCC $30.45
- SNAL $26.17
- Revenue Growth
- ICCC 21.75
- SNAL 46.95
- 52 Week Low
- ICCC $3.34
- SNAL $0.64
- 52 Week High
- ICCC $7.60
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- ICCC 38.90
- SNAL 37.29
- Support Level
- ICCC $5.92
- SNAL $0.94
- Resistance Level
- ICCC $6.90
- SNAL $1.10
- Average True Range (ATR)
- ICCC 0.36
- SNAL 0.09
- MACD
- ICCC -0.05
- SNAL -0.00
- Stochastic Oscillator
- ICCC 0.00
- SNAL 27.91
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.